Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12373417rdf:typepubmed:Citationlld:pubmed
pubmed-article:12373417lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:12373417lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:12373417lifeskim:mentionsumls-concept:C0699864lld:lifeskim
pubmed-article:12373417lifeskim:mentionsumls-concept:C0947647lld:lifeskim
pubmed-article:12373417lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12373417lifeskim:mentionsumls-concept:C0304403lld:lifeskim
pubmed-article:12373417pubmed:issue1lld:pubmed
pubmed-article:12373417pubmed:dateCreated2002-10-9lld:pubmed
pubmed-article:12373417pubmed:abstractTextIn studies assessing sustained attention in humans, performance is often characterised by a decline in function over time. This response pattern, termed the vigilance decrement, is sensitive to manipulations affecting task difficulty, and to reversal with psychostimulant drugs. A valid test of attention in non-human species requires both comparable characteristics of performance, and sensitivity to similar psychoactive drugs. The five-choice serial reaction time task (5-CSRTT) has been described as a test of sustained attention in the rat, however, studies describing vigilance decrements and performance effects of psychostimulants in this task are scarce.lld:pubmed
pubmed-article:12373417pubmed:languageenglld:pubmed
pubmed-article:12373417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12373417pubmed:citationSubsetIMlld:pubmed
pubmed-article:12373417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12373417pubmed:statusMEDLINElld:pubmed
pubmed-article:12373417pubmed:monthOctlld:pubmed
pubmed-article:12373417pubmed:issn0033-3158lld:pubmed
pubmed-article:12373417pubmed:authorpubmed-author:HigginsGuy...lld:pubmed
pubmed-article:12373417pubmed:authorpubmed-author:GrottickAndre...lld:pubmed
pubmed-article:12373417pubmed:issnTypePrintlld:pubmed
pubmed-article:12373417pubmed:volume164lld:pubmed
pubmed-article:12373417pubmed:ownerNLMlld:pubmed
pubmed-article:12373417pubmed:authorsCompleteYlld:pubmed
pubmed-article:12373417pubmed:pagination33-41lld:pubmed
pubmed-article:12373417pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:meshHeadingpubmed-meshheading:12373417...lld:pubmed
pubmed-article:12373417pubmed:year2002lld:pubmed
pubmed-article:12373417pubmed:articleTitleAssessing a vigilance decrement in aged rats: effects of pre-feeding, task manipulation, and psychostimulants.lld:pubmed
pubmed-article:12373417pubmed:affiliationPRBN-B, F. Hoffmann-La Roche AG, 4070 Basel, Switzerland. agrottick@arenapharm.comlld:pubmed
pubmed-article:12373417pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12373417pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12373417lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12373417lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12373417lld:pubmed